Our members
Oslo Cancer Cluster members are Norwegian and international companies, research and financial institutions, university hospitals and organisations – all working in the field of cancer. They represent the oncology value chain.
All members
EXACT Therapeutics is a clinical-stage Norwegian biopharmaceutical company specializing in ultrasound-mediated drug delivery. Their proprietary Acoustic Cluster Therapy (ACT®) platform follows a unique approach to targeted drug enhancement, with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across multiple indications, including oncology and brain diseases.
Visit
Oslo Metropolitan University ( OsloMet ) is a urban state university in Oslo and Akershus in Norway. The university is committed to providing research-based knowledge related to the welfare state and aims to respond to the needs of society and the labour market.
Visit
GE Healthcare AS provides healthcare products. The subsidiary in Oslo produces and markets contrast agents for X-rays, MRIs, ultrasounds, and radiopharmaceuticals that enable predictability and diagnosis of diseases at an early stage.
Visit
GlaxoSmithKline AS is the Norwegian affiliate of GlaxoSmithKline plc. The company is a research-based pharmaceutical and healthcare company with several pioneering products in prescription medicines, oncology, and vaccines. The company in Norway is also focused on clinical trials.
Visit
Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment. The company's tests leverage innovations in genomic technology and machine learning to enable diagnostic, prognostic and treatment decisions in challenging diseases such as lung cancer, prostate and bladder cancers, thyroid cancer, breast cancer, colon cancer and idiopathic pulmonary fibrosisment decisions throughout the patient journey in cancer and other diseases.
Visit
HealthCap is a family of multi stage venture capital funds, investing globally in life sciences, with the Odlander Fredrikson Group as the exclusive investments advisor. With committed capital exceeding a 800 million, HealthCap is one of the largest specialized provider of venture capital within life sciences Europe.
Visit
Helse Stavanger is a university and acute care hospital in Norway. The hospital offers patient care, research, education of health professionals and patient education.
Visit
Hemispherian is an innovative pharmaceutical company focused on developing a novel class of small molecule drugs (GLIX). GLIX compounds target the TET2 enzyme and activate the DNA damage response resulting in cancer cell death. The company’s lead compound, GLIX1, is in late-stage preclinical development for the treatment of glioblastoma, a deadly cancer of the central nervous system and the leading cause of death by disease in children. Hemispherian’s further advances GLIX5 for the treatment of platinum-resistant ovarian cancers.
Visit
Eli Lilly and Company is a healthcare company that is engaged in the discovery, development, and marketing of human healthcare products. Lilly Norway, the Eli Lilly Norge AS, is part of the Northern European hub, which consists of the Nordic countries, Great Britain and Ireland. The company's line of business includes providing research, development, manufacturing, and marketing of prescription medicines including treatments in bone, musculoskeletal, cancer, diabetes, endocrine, immunological, neurodegeneration, neuroscience and pain.
Visit
DoMore Diagnostics uses artificial intelligence to make personalized treatment decisions simple and accessible for all cancer patients. Its unique digital biomarkers predict patient outcomes from routine tumor tissue slides and can be seamlessly integrated into pathologists’ existing workflow. The lead product Histotype Px® Colorectal is a CE-IVDD marked outcome prediction marker for stage II and III colorectal adenocarcinoma that informs the decision of whether to provide adjuvant chemotherapy following surgical resection of the tumor.
Visit
Agilera Pharma AS is a contract development and manufacturing organisation (CDMO) that contributes to technology development and growth in the radiopharmaceuticals market. The company provides expertise and infrastructure that makes it possible to bring new, innovative radiopharmaceuticals from concept to clinic and onward to commercialisation.
Visit
iNANOD AS is a nanotechnology based anticancer drug developing company. iNANOD`s research utilizes nanotechnology-based platform, improving the efficacy and reducing side-effects of chemotherapeutic medications by optimizing drug delivery platform. This approach aims to ensure an optimal targeting and concentration of delivered drugs to the diseased tissue while generating immunotherapy.
Visit
Inven2 AS is established to maintain and develop Norwegian innovations. The company build bridges between research and the next generation technology based industry. The company engages in the commercialization of innovations from owners, administration of research funds, and administration and financial follow up of clinical trials.
Visit
TheVIT AS offer services in finance, analysis, HR and business development adapted to a rapidly developing business world. The firm tailors fact-based management information and makes it available using new technology. The firm also offer a full-fledged back-office offer, where various specialists are offered to customers, based on the customer's needs and with a great degree of flexibility.
Visit
Kelly specializes in recruiting, personnel leasing, outsourcing and advice in restructuring processes. Kelly Services in Norway with offices in Oslo, Kristiansand, Stavanger, Bergen and Trondheim. In addition, the company owns recruitment offices in Yokohama, Moss, Kongsberg and Ågotnes. The company recruits for permanent and temporary positions in a variety of disciplines, both in the private and public sectors.
Visit
Kongsberg Beam Technology developed the precision technology MAMA-K designed to improve the accuracy of proton therapy in combating cancer. The equipment is sold to hospitals that need to upgrade their PRT system(s) and OEM agreements with one or several manufacturers of PRT systems. MAMA-K includes a digital twin, a dynamic copy of the patient and it is based on input from different sensors and images. The purpose of MAMA-K is to maximize the effect of the radio therapeutic treatment inside the tumor beyond the level of any existing solutions at the same time as the radiation effect on surrounding tissue is reduced to a minimum.
Visit
The Norwegian Cancer Society is a nationwide, voluntary organisation dedicated to the cancer cause. The society is an NGO in Norway and contributes to a focused effort in the area of research funding, cancer care, cancer prevention, information and international collaboration.
Visit
The Cancer Registry of Norway was established to collect data and produce statistics of the cancer prevalence in Norway, and has a research activity. The Cancer Registry is also responsible for the national screening programmes: Breast Cancer Screening Programme and Cervical Cancer Screening Programme. The goal of which is to prevent cancer death by discovering cancer or pre cancerous lesions as early as possible.
Visit
Ledidi AS develops and delivers tools to the health industry and health research community. Ledidi's projects combine project definition, data management, analysis and reporting. Ledidi develops an integrated cloud application as a true end-to-end solution for research projects and registries, including the design and set up of a database or registry.
Visit
LINK Medical is a full-service contract research organization (CRO) providing product development services for the pharmaceutical and medical device industries across Northern Europe. The company offers various services within the clinical trials, regulatory affairs, pharmacovigilance, health economics and quality assurance.
Visit
Augere Medical is a startup that develops cutting-edge AI to medical devices. The company's goal is to reduce human variability in the inspection of diagnostic videos, and the patent-pending technology allows the system to take time and context into account when video is analysed in real-time. The first product developed is for colorectal cancer detection and prevention.
Visit
Lytix Biopharma is a clinical-stage biotech company developing proprietary oncolytic peptides as a novel immune therapy to fight cancer. The company's product LTX-315, is a first-in-class oncolytic molecule representing a new principle to boost anti-cancer immunity.
Visit
Merck AB, Norway offers customers in Norway a wide range of products - from innovative prescription drugs and over-the-counter medicines to life science solutions, industrial pigments and chemicals. The Merck AB operates as a branch office in norway.
MSD (Norway) AS is a subsidiary company of Merck & Co., Inc. The company provides research & development, manufacturing, and sales of health solutions and therapies. The company develops medicines in the area including cancer, hepatitis C, cardio-metabolic disease, antibiotic-resistant infection and Alzheimer's disease. The company is also active in the women's area, which provides contraception, infertility treatment and against osteoporosis.
Miphic offers a high-throughput mitochondrial screening platform for the diagnosis of various diseases including, cancer, neurodegenerative disease, diabetes and aging. The company performs multiparametric mitochondrial screening within three main domains: metabolic drug discovery, personalized medicine choice and fundamental research on metabolism.
Visit
Nextera AS focuses on target discovery and drug development in the immunotherapy space for autoimmune, chronic diseases, and oncology by addressing the initiation of the immune response; the interaction between T cells and antigen-presenting cells. The company's unique drug discovery platform, NextCore opens a new space for drug discovery in the development of ACT and ADCs. Nextera has already two assets ready for licensing; Highly specific T Cell-Receptors (TCRs) for immuno-oncology and TCR-like antibodies as a therapy in Celiac disease.
NorGenoTech is a biomedical technology company providing analysis of DNA damage. The company develops equipment, carries out research projects and offers services and training courses. The company provides services to hospitals, research labs, chemical and pharma industries and regulators. The company's technology is the comet assay, a diagnostic tool in personalized medicine and is used in human bio-monitoring and for industrial testing of chemicals and drugs.
Visit
Novartis Norge AS researches develops, manufactures, and markets healthcare and pharmaceutical products worldwide. Novartis Norway has a special unit that conducts clinical research where Norwegian patients and physicians participate.
Visit
Oncoinvent AS is a clinical stage company developing radiopharmaceutical technology that delivers precise, alpha-emitting particles across solid cancers. By leveraging internal manufacturing and supply chain capabilities to enable a clinical supply of radioisotopes, the company is advancing a pipeline of novel products that use alpha particles, a higher Linear Energy Transfer (LET) form of radiation, that can potentially eradicate cancer cells. Oncoinvent’s lead candidate, Radspherin®, is designed for treatment of metastatic cancers in body cavities, and the versatility allows it to be deployed for the treatment of a variety of cancer indications. Radspherin® is in two ongoing clinical studies to treat peritoneal carcinomatosis from both ovarian cancer and colorectal cancer.
Visit
PCI Biotech (OSE:PCIB) is a biopharmaceutical company focusing on development and commercialisation of novel therapeutic solutions for improved treatment of cancer patients through its innovative photochemical internalisation (PCI) technology platform. PCI induces triggered endosomal release that can be used to unlock the true potential of a wide array of therapeutic modalities.
ARTBIO is a clinical-stage radiopharmaceutical company redefining cancer care by creating a new class of alpha radioligand therapies (ARTs). The unique ARTBIO approach selects the optimal alpha-emitting isotope (Pb212) and tumor-specific targets to create highly targeted therapeutics. The company's AlphaDirect™ technology, a first-of-its-kind Pb212 isolation method, enables a distributed manufacturing approach for the reliable production and delivery of ARTs. ARTBIO is advancing three pipeline programs with lead program AB001 currently in first in human trials.
Visit
Pfizer discovers, develops, manufactures, and markets prescription medicines for humans and animals and many of the world's best-known consumer brands. Pfizer operates in Norway with five main categories in pharmaceuticals: established pharmaceuticals, innovative drugs, oncology, vaccines, and consumer health.
Visit
PharmaRelations AS is a consulting and interim company specialized in life science, that offers services of hiring, consulting and recruitment. The industries served by the company particularly include, pharmaceuticals, medical technology, biotechnology, self-care, dental care and animal health.
Visit
SurViva As has extensive experience and network in the Norwegian life science sector. The company is providing consultancy services related to competence and capabilities in product development for health and pharma. They also have access to infrastructure for product development, and provide practical services in chemistry scale up and spray granulation.
Visit
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. The photodynamic technology combines the application of a drug that selectively targets diseased cells with exposure to light. Depending on the combination of drug, wavelength and exposure time the technology can be used for diagnostic or therapeutic use.
Visit
Potter Clarkson LLP is an award-winning firm of European patent and trademark attorneys and IP lawyers, and full-service intellectual property practices in Europe. They also offer IP news, training, and events for clients and other interested parties, including seminars and webinars.
Precision for Medicine, Oncology and Rare Disease is an oncology specialty contract research organization which provides clinical research services. The company provides application of metrics-driven project management to optimize oncology drug development.
Visit
Cody AS is an engineering company that develops, designs, and builds custom tailored production equipment, machinery, and prototypes. The company's core competencies are mechanical and electrical design, robotics, cybernetics, automation, industrial IT, and complex system integrations.
Visit
PubGene develops bioinformatics solutions for microarray approaches, including gene and protein arrays. PubGene provides a unique software-as-a-service platform, Coremine, which enables domain-specific community portals combining context networks. Coremine Medical provides qualified connections between medical concepts such as diseases, drugs, treatments, symptoms, genes and medical experts.
Visit
Radforsk Investeringsstiftelse (Radforsk) is an early stage evergreen fund that acts as a hub for oncology and player working in every part of the research–to–commercialization eco-system The objective of the foundation is to identify cancer and oncology research. Radforsk invest in oncology, novel therapeutics and diagnostics, with a key focus on immuno-oncology. Since its establishment, Radforsk Investeringsstiftelse has invested in and been an active owner of more than twenty companies, and currently holds 13 companies.
Visit
Roche Norway AS focuses on sales and marketing of pharmaceuticals. The company focuses on drugs in the field of cancer, immunology, infectious diseases, ophthalmology and neurology.
SANDS Advokatfirma DA is a legal advisor for Norwegian and international global corporations in relation to domestic and international projects. The company provides assistance within a wide scope of business legal areas, with the main focus on clients within the industry and the public sector. The company offers expertise within all business legal disciplines and is also council solicitor for a number of municipals in the county.
Visit
Sanofi-Aventis Norge AS develops, manufactures and distributes prescription drugs, proprietary drugs, and toiletries. The company offers products in the treatment of diabetes, cancer, cardiovascular disease, and other disorders to healthcare providers, researchers, clinics, and facilities throughout Norway and internationally.
Visit
Sarsia Seed is a venture capital investor based in Bergen, Norway. The company invests in early-stage science and technology based companies operating in the areas of Energy / Technology and Biotechnology / Life Sciences.
Visit
SINTEF is an independent, not-for-profit research institute. The institute conducts contract research & development as partner for the private and public sectors.The strategic focus areas of the institute includes renewable energy, climate and environmental technology, oil and gas, ocean space technology, health and welfare, and enabling technologies. SINTEF is certified in accordance with ISO 9001:2015, ISO 14001:2015 and OHSAS 18001:2007 standards.
Visit
NaDeNo Nanoscience AS was established with the aim to offer the proprietary platform technology to pharma and biotech companies in need of overcoming drug delivery hurdles of drugs, with initial internal focus on repurposing of effective drugs in areas of high unmet medical need. The company's lead candidate is PACAB-002, which are polymeric nanoparticles encapsulating cabazitaxel.
Visit
Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. The company partners with emerging and large biopharma and medical device and diagnostic companies to drive healthcare innovation throughout the world.
Visit
Alv B is a Oslo based biotech company developing immunotherapy, as well as other experimental cancer therapeutics for dogs and cats. The company's products include Alvacan 1000 & 4000, Alvacan XO, etc.
Visit
Daiichi Sankyo Nordics is a part of Daiichi Sankyo. The company aim at contributing to timely access of new treatment options to give more people impacted by cancer more time with their loved ones. The company operates as a marketing company of Daiichi Sankyo Europe Group.
Visit
Thelper AS is a Norwegian early-phase Biotech company that is developing first-in-class antibody-drug conjugates (ADC) against a novel, virally encoded, oncogenic target protein. The target is highly cancer specific, and is widely and homogeneously expressed across aggressive tumors and their metastases. Thelper aims to revolutionize cancer treatment with its first-in-class ADC, by providing a therapeutic option that can enhance patient survival with fewer side effects.
Visit
Theradex Oncology provides global clinical development services exclusively to companies developing new cancer treatments. The company has a strong emphasis on early drug development. The company provides regulatory and medical support for companies taking cancer treatments into clinical development in the US and Europe.
Thermo Fisher Scientific offers analytical instruments as well as laboratory equipment, software, services, consumables and reagents used in scientific research, safety, healthcare and science education. In Norway, the company operates as a subsidiary of Thermo Fisher Scientific Inc.
Visit
Diffia AS is a digital health tech company established with a focus to support the healthcare industry. The company has developed Nimble - a mobile clinical solution designed for hospital, doctors and nurses. Nimble is an app for hospital employees that simplifies communication, record keeping and retrieval of important information. The app offers functions such as message exchange, image capture and note writing, and takes care of all necessary patient safety.
Visit
Ultimovacs is a clinical-stage biotechnology company which specializes in immunotherapeutic cancer vaccines with broad applicability. Ultimovacs’ lead candidate, UV1, is an off-the-shelf therapeutic cancer vaccine directed against human telomerase (hTERT), an antigen that is present in 85-90% of cancers in all stages of tumor growth. A broad clinical program, with Phase II trials in five cancer indications enrolling more than 670 patients, aims to demonstrate UV1’s impact in combination with other immunotherapies in multiple cancer types expressing telomerase and where patients have unmet medical needs. UV1 is a patented technology owned by Ultimovacs.
Visit
Node Pharma is a preclinical radiopharmaceutical company developing new therapies for cancer patients with limited treatment options.
Visit
Gilead Sciences is the biopharmaceutical company whose mission is to discover, develop and deliver innovative therapeutics for people facing life-threatening diseases. The company focuses on treatments for HIV, viral hepatitis, cancer and other fungal infections. Moreover Gilead Sciences, Nordics supports patient advocacy organizations, healthcare professionals and nonprofit groups to advance education among healthcare professionals, patients, and community members for creating the better healthcare. The company is effective in making collaboration and partnership with healthcare systems and patient groups.
Visit
The University of Oslo focuses on the research and offers a variety in study options. The faculties include (Lutheran) Theology, Law, Medicine, Humanities, Mathematics, natural sciences, social sciences, Dentistry, and Education.
Visit
Nykode Therapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies with a focus on the treatment of cancer and autoimmune diseases. Nykode’s modular vaccine technology specifically targets antigens to antigen presenting cells (APC), which have been shown to induce a broad, strong and long-lasting antigen specific immune response in cancer, which correlates with clinical responses.
Visit
NordicRWE is a Norwegian Real-world Evidence (RWE) start-up company that has the ambition to be at the forefront of the data-driven drug development and life cycle process. The company provides crucial insight into different steps in the drug development cycle and give evidence that accelerates development, approvals and access as well as benefit/risk surveillance. The vision of NordicRWE is to develop a research-based system for RWE that supports drug development in accordance with high regulatory demands.
Visit
Worldwide Clinical Trials is a global contract research organization that provides preclinical and Phase I-IV clinical development services to the biotechnology and pharmaceutical industries. The company offers full-service clinical experience that ranges from early phase and bioanalytical sciences through late phase studies, post approval, and real-world evidence. The company's major therapeutic areas of focus include cardiovascular, metabolic, neuroscience, oncology, and rare diseases.
Zelluna Immunotherapy’s mission is to eliminate solid cancers by unleashing the most powerful elements of the immune system through pioneering the development of T cell receptor (TCR) guided natural killer (NK) cell therapies. The company focuses on developing a portfolio of tumor-specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient, and durable to patients.
Visit
The Brain Tumor Association is the association of people who are diagnosed with brain tumors and their relatives.The association makes good connection with the neurosurgery and neurological departments of the hospitals to ensure better treatment. The firm is collaborated with the Norwegian Cancer Society for rehabilitation, research and relative work.
Visit
Expert Analytics is a software consultancy, that offers software solutions for industrial applications to both domestic and international customers. The company uses, scientific methodology to model and implement tailored solutions for various industrial challenges.
Visit
NEC Corporation is a leading Japanese technology firm. It manufactures PCs, computer platforms, semiconductors, and display panels; builds broadband and mobile communication networks; and provides systems-integration services. The firm's research and development has funded accomplishments such as breakthroughs in quantum computing and PDA speech-translation software.
MultiplexDX Inc. is developing multiplexed, accurate, quantitative and accessible diagnostic tests for cancer and covid. The company's products include rTest COVID-19 qPCR SuperRapid, Vivid COVID-19 LAMP Direct-G diagnostic kit, rTest COVID-19 qPCR Superplex Kit, etc.
AbbVie is a research-based biopharmaceutical company. The company's mission is to develop and market advanced therapies in the areas of hepatitis C (HCV), neuroscience, immunology, oncology, etc.
Visit
AdjuTec Pharma AS is a Norwegian pharmaceutical start-up company. The company is a developer of antibiotic resistance breakers designed to meet the imminent threat to modern medicine of antimicrobial resistance. AdjuTec's core technology is synthesis of β-lactamase inhibitors that inactivates bacteria resistance enzymes by taking down bacteria defense, enabling researchers to preserve the susceptibility of broad-spectrum antibiotics.
Visit
Akershus University Hospital (Ahus) provides treatments that safeguard and promotes patients' health. The hospital delivers specialists in somatic health care, mental health, and substance abuse.
Visit
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. Amgen Norge operates as the sales office of Amgen Inc.
Visit
APIM Therapeutics AS renders biotechnology services. The company develops a series of proprietary protein interaction-blocking peptides targeting complexes formed between proliferating cell nuclear antigens and proteins bearing a novel PCNA-interacting peptide motif, enabling healthcare professionals to eliminate and cure cancer-specific tumor cells.
Visit
Arctic Pharma AS is engaged in developing anti-cancer drugs for glycolytic cancers by exploiting the cancer cells and their peculiar metabolic features. The company is focused on developing anti-cancer drugs by exploiting the “sweet tooth” of cancer cells. Arctic Pharma has designed inhibitors that can directly target key enzymes that are upregulated in cancer cell metabolism.
Visit
Astellas Pharma is a research-oriented global pharmaceutical company operating in about 50 countries with a focus on ethical pharmaceuticals. The company focuses on the areas like urology, immunology, infectious diseases, oncology, neuroscience, etc.
Visit
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & Immunology. In AstraZeneca Norway, primarily the company work with sales and marketing of innovative medicines.
Visit
Bayer AS develop new molecules for use in innovative products and solutions to contribute to better health for people, animals and plants. Bayer's activities in research and development are based on a deep understanding of the biochemical processes in living organisms.
Visit
Birk Venture is a venture capital firm specializing in early stage companies. The firm invests in small size and start-up companies with a unique technology. The company invests in the life science industry with a special focus on pharmaceuticals, biotechnology, diagnostics, medical devices and instruments, and consumer health.
Visit
Randstad is a HR services provider. The firm offers staffing and recruitment with a focus on HR, purchasing, administration, market, sales, customer service, warehousing, logistics, production and care.
Visit
Bristol-Myers Squibb operates as a biopharmaceutical company, which engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products. The company in Norway focuses on sales and services and also supports hospital clowns.
Visit
Culture Intelligence is a software company with the mission to simplify culture transformation by enabling leaders to assess, analyze and rebuild their culture whenever it is needed.
Visit
Johnson & Johnson operates as a clinical research, marketing, and sales company for Janssen's prescription and non-prescription drugs. The company's line of business includes the wholesale distribution of prescription drugs, proprietary drugs, and toiletries.
Visit
Labcorp Drug Development is a contract research organization providing nonclinical, preclinical, clinical, and commercialization services to the pharmaceutical and biotechnology industries. The company offers scalable solutions, covering the spectrum from large-scale clinical trial testing to custom assay development.
Visit
Curida is a contract development and manufacturing organization for pharmaceuticals. The company offers manufacturing services to international pharma companies. The company has a core competency in sterile and aseptic manufacturing of liquid pharmaceuticals.
Visit
Exact Sciences Corp. is a molecular diagnostics company specializing in the detection of early-stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX, a gene expression test for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services.
Visit
DNB ASA is a financial services group. The company offers a full range of financial services, including loans, savings, advisory services, insurance and pension products for retail and corporate customers.
Visit
Oncosyne AS is a biotechnology start-up which cultivate the patient’s own living cancer cells and test them against an array of clinically relevant drugs and drug combinations. The company's vision is to provide functional diagnostic tools that give cancer patients significantly better and longer lives.
Visit
